Top Markets
Coin of the day
Sandoz Group AG Sandoz Group AG

Sandoz Group AG

SDZ
Rank in Stocks #622
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Share Price
$95.44
Last synced: 2026-08-24
Market Cap
$41.29B
Change (1 day)
-0.62%
Change (1 year)
52.20%
Country
CH
Trade Sandoz Group AG (SDZ)

Category

P/B ratio for Sandoz Group AG (SDZ)
P/B ratio as of 2026 TTM: 0
According to Sandoz Group AG latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Sandoz Group AG from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors